Ortikos 9mg ER Capsules

Manufacturer FERRING Active Ingredient Budesonide Extended-Release Capsules (Ortikos)(byoo DES oh nide) Pronunciation byoo-DES-oh-nide
It is used to treat Crohn's disease.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Corticosteroid, Anti-inflammatory
đŸ§Ŧ
Pharmacologic Class
Glucocorticoid
🤰
Pregnancy Category
Not available
✅
FDA Approved
Jan 2017
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Ortikos is a medicine called a corticosteroid that helps reduce inflammation in your colon. It's used to treat mild to moderate ulcerative colitis. Unlike some other steroids, Ortikos is designed to work mainly in your gut, which helps reduce side effects on the rest of your body.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely. Take your medication in the morning, with or without food, as directed by your doctor. Swallow the tablet whole - do not chew, open, or crush it. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel well.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep the lid tightly closed and store all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take Ortikos exactly as prescribed, usually once daily in the morning.
  • Swallow the capsules whole; do not chew, crush, or break them.
  • Avoid eating grapefruit or drinking grapefruit juice while taking this medication, as it can increase the amount of budesonide in your body and lead to more side effects.
  • Inform your doctor if you are exposed to chickenpox or measles, as you may be at higher risk of severe infection.
  • Carry a steroid warning card if your doctor advises, especially if you are at risk for adrenal suppression.
  • Do not stop taking Ortikos suddenly without consulting your doctor, as this can lead to withdrawal symptoms or adrenal insufficiency.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 9 mg orally once daily in the morning for up to 8 weeks
Dose Range: 9 - 9 mg

Condition-Specific Dosing:

active_mild_moderate_ulcerative_colitis: 9 mg orally once daily in the morning for up to 8 weeks. For patients who complete an 8-week course and remain symptomatic, an additional 8-week course may be considered.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and effectiveness not established in pediatric patients)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; budesonide is highly protein bound and unlikely to be removed by dialysis.

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Consider reducing dose or avoiding use due to increased systemic exposure. Monitor for signs of hypercorticism.
Severe: Avoid use due to significantly increased systemic exposure and risk of hypercorticism.
Confidence: High

Pharmacology

đŸ”Ŧ

Mechanism of Action

Budesonide is a glucocorticosteroid that exerts potent anti-inflammatory effects. It acts by binding to glucocorticoid receptors, leading to the transcription of anti-inflammatory proteins and the inhibition of pro-inflammatory mediators. In the context of ulcerative colitis, the extended-release formulation delivers budesonide to the colon, where it acts locally to reduce inflammation with reduced systemic exposure due to extensive first-pass metabolism.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 10-20% (due to extensive first-pass metabolism)
Tmax: Approximately 10-12 hours (for ER capsules)
FoodEffect: High-fat meal may delay Tmax but does not significantly affect AUC or Cmax.

Distribution:

Vd: Approximately 2.2-3.9 L/kg
ProteinBinding: Approximately 85-90%
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 2-3.6 hours (systemic)
Clearance: Approximately 10-15 L/hr (in healthy subjects)
ExcretionRoute: Primarily renal (approximately 60%) and fecal (approximately 40%) as metabolites
Unchanged: Less than 1% (in urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Clinical improvement typically seen within 2-4 weeks
PeakEffect: Not precisely defined for clinical effect, but peak plasma concentrations occur at 10-12 hours.
DurationOfAction: Once daily dosing supports sustained therapeutic levels for 24 hours.
Confidence: High

Safety & Warnings

âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased sputum production or change in sputum color
+ Pain while passing urine
+ Mouth sores
+ Wounds that will not heal
Skin changes, including:
+ Pimples
+ Stretch marks
+ Slow healing
+ Hair growth
Purple, red, blue, brown, or black bumps or patches on the skin or in the mouth
Signs of high blood pressure, such as:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Signs of a weak adrenal gland, including:
+ Severe upset stomach or vomiting
+ Severe dizziness or passing out
+ Muscle weakness
+ Feeling very tired
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of Cushing's syndrome, such as:
+ Weight gain in the upper back or belly
+ Moon face
+ Severe headache
+ Slow healing
Unexplained bruising or bleeding
Black, tarry, or bloody stools
Vomiting blood or coffee ground-like material
Swelling in the arms or legs
Shortness of breath
Bone pain
Changes in eyesight

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:

Headache
Signs of a common cold
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Heartburn
Gas
Feeling dizzy, tired, or weak
Back pain
* Joint pain

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of infection: fever, chills, sore throat, body aches, unusual tiredness, or flu-like symptoms.
  • Signs of adrenal insufficiency: severe tiredness, weakness, nausea, vomiting, dizziness, lightheadedness, or fainting.
  • Signs of too much steroid: increased thirst or urination, increased appetite, weight gain, swelling in your hands or feet, muscle weakness, mood changes, or skin problems (thinning, easy bruising).
  • Severe abdominal pain or worsening of ulcerative colitis symptoms.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including the symptoms that occurred.
If you have liver disease, as this may affect the medication's efficacy or increase the risk of side effects.
If you have any type of infection, such as bacterial, viral, or fungal infections, including:
+ Amoeba infection (e.g., traveler's diarrhea)
+ Herpes infection of the eye
+ Malaria infection in the brain
+ Threadworm infestation
+ Other infections

Additionally, tell your doctor about all the medications you are taking, including:

Prescription and over-the-counter (OTC) medications
Natural products
Vitamins

Some medications, such as those used to treat HIV, infections, depression, and other conditions, may interact with this medication and should not be taken together. Your doctor or pharmacist can advise you on potential interactions.

This is not an exhaustive list of all possible interactions. Therefore, it is crucial to discuss all your medications and health conditions with your doctor and pharmacist to ensure safe treatment. Do not start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Information About Your Medication

It is crucial that you inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests, as directed by your doctor, are necessary to monitor your health. If you are taking this medication long-term, you may also need to have your eye pressure and bone density checked.

Taking Your Medication as Directed

Do not take this medication for a longer period than prescribed by your doctor. If you have diabetes, it is essential to closely monitor your blood sugar levels. If you have been taking this medication for an extended period, consult your doctor before stopping, as you may need to gradually taper off the medication.

Infection Risks and Precautions

Steroid medications, including this one, can increase the risk of infection. They can worsen existing infections and make it more challenging to detect signs of infection. Infections can range from mild to severe and potentially life-threatening. The risk of infection is higher with higher doses of steroids. To minimize this risk, wash your hands frequently, avoid close contact with people who have infections, colds, or flu, and notify your doctor if you experience any signs of infection.

Reactivation of Infections

Certain infections, such as tuberculosis and hepatitis B, can reactivate in patients taking medications like this one. Inform your doctor if you have a history of these infections.

Viral Infections

If you have not had chickenpox or measles before, avoid close contact with anyone who has these infections, as they can be severe or even life-threatening in people taking steroid medications. If you have been exposed to chickenpox or measles, consult your doctor.

Adrenal Insufficiency

This medication may decrease the natural production of steroids in your body. If you experience a fever, infection, surgery, or injury, consult your doctor, as you may require additional oral steroids to help your body cope with these stresses. Carry a warning card indicating that you may need extra steroids in certain situations.

Long-term Use and Potential Side Effects

Long-term use of this medication may increase the risk of osteoporosis (weak bones). Discuss your risk factors with your doctor. Additionally, long-term use may raise the risk of cataracts or glaucoma. Consult your doctor if you have any concerns.

Interactions and Precautions

Avoid consuming grapefruit and grapefruit juice while taking this medication. Before receiving any vaccines, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

Missed Doses and Stopping the Medication

If you miss a dose or recently stopped taking this medication and experience fatigue, weakness, shakiness, rapid heartbeat, confusion, sweating, or dizziness, inform your doctor.

Rare but Serious Side Effects

There is a potential risk of developing Kaposi's sarcoma, a type of cancer, with long-term use of medications like this one. Discuss this risk with your doctor.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. This medication may affect growth in children and teenagers, and regular growth checks may be necessary. Consult your doctor if you have any concerns.

Pregnancy and Breastfeeding

This medication may harm an unborn baby if taken during pregnancy. If you become pregnant or are planning to become pregnant, inform your doctor immediately. If you are breastfeeding, discuss the potential risks to your baby with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Acute overdose is unlikely to cause clinically significant problems due to the drug's low systemic bioavailability and extensive first-pass metabolism. However, chronic overdose may lead to signs of hypercorticism (Cushing's syndrome) and adrenal suppression.

What to Do:

There is no specific antidote. Treatment is supportive and symptomatic. In case of suspected overdose, contact a poison control center (1-800-222-1222) or seek emergency medical attention immediately.

Drug Interactions

🔴

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, nelfinavir, grapefruit juice): Concomitant use can significantly increase systemic exposure to budesonide, leading to increased risk of Cushing's syndrome and adrenal suppression. Avoid concomitant use.
🟡

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil): May increase budesonide exposure; monitor for corticosteroid side effects.
  • Oral contraceptives: May increase budesonide exposure; monitor for corticosteroid side effects.
  • Live attenuated vaccines: May reduce immune response to vaccines and increase risk of adverse reactions from live vaccines. Avoid administration of live vaccines to patients receiving immunosuppressive doses of corticosteroids.
đŸŸĸ

Minor Interactions

  • Cimetidine: May slightly increase budesonide exposure, but generally not clinically significant.
  • Omeprazole: No significant interaction.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Adrenal function (e.g., morning cortisol levels)

Rationale: To assess baseline adrenal axis status, especially if transitioning from systemic corticosteroids or if adrenal suppression is suspected.

Timing: Prior to initiation, especially if long-term systemic corticosteroid use has occurred.

Bone mineral density (BMD)

Rationale: To assess baseline bone health, particularly in patients at risk for osteoporosis or with long-term corticosteroid exposure.

Timing: Prior to initiation, especially for prolonged use.

📊

Routine Monitoring

Signs and symptoms of hypercorticism (e.g., Cushing's syndrome)

Frequency: Regularly during treatment, especially if dose is increased or if patient is on concomitant CYP3A4 inhibitors.

Target: Absence of signs/symptoms

Action Threshold: If signs/symptoms develop, consider dose reduction, discontinuation, or alternative therapy.

Signs and symptoms of adrenal suppression/insufficiency

Frequency: Regularly, especially during dose reduction or discontinuation, or during periods of stress.

Target: Absence of signs/symptoms (e.g., fatigue, weakness, nausea, vomiting, hypotension)

Action Threshold: If symptoms occur, consider exogenous corticosteroid supplementation during stress or re-evaluate therapy.

Electrolytes (especially potassium)

Frequency: Periodically, especially in patients at risk for hypokalemia.

Target: Within normal limits

Action Threshold: If abnormal, correct electrolyte imbalance and investigate cause.

Growth (in pediatric patients, if used off-label)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age

Action Threshold: If growth suppression is observed, re-evaluate therapy.

đŸ‘ī¸

Symptom Monitoring

  • Signs of infection (fever, chills, increased pain, malaise)
  • Symptoms of adrenal insufficiency (fatigue, weakness, nausea, vomiting, dizziness, hypotension)
  • Symptoms of hypercorticism (moon face, central obesity, striae, acne, hirsutism, easy bruising)
  • Changes in mood or behavior (irritability, depression, euphoria)
  • Gastrointestinal symptoms (abdominal pain, diarrhea, rectal bleeding) to assess disease activity

Special Patient Groups

🤰

Pregnancy

Risk Summary: Limited data on budesonide use in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. However, budesonide is a corticosteroid, and corticosteroids can cross the placenta. Animal reproduction studies with budesonide have shown adverse developmental effects (e.g., increased fetal loss, decreased pup weights, skeletal abnormalities) at doses that were maternally toxic. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of oral clefts has been suggested with systemic corticosteroids, but data for budesonide are limited and inconsistent. Risk appears low with inhaled/local formulations.
Second Trimester: Risk of fetal growth restriction or other adverse effects with prolonged systemic corticosteroid use.
Third Trimester: Risk of adrenal suppression in the neonate if used systemically in late pregnancy. Monitor neonates for signs of hypoadrenalism.
🤱

Lactation

Risk Summary: Budesonide is present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Ortikos and any potential adverse effects on the breastfed infant from Ortikos or from the underlying maternal condition. Limited data suggest that the total daily oral dose of budesonide available to the infant via breast milk is low.

Infant Risk: Low risk. Monitor breastfed infants for signs of systemic corticosteroid effects (e.g., growth suppression, adrenal suppression) if the mother is receiving high doses or prolonged therapy, though unlikely with typical Ortikos dosing.
đŸ‘ļ

Pediatric Use

Safety and effectiveness of Ortikos have not been established in pediatric patients. Ortikos is not approved for use in pediatric patients with ulcerative colitis.

👴

Geriatric Use

No overall differences in safety or effectiveness were observed between elderly and younger patients. However, greater sensitivity of some older individuals cannot be ruled out. Monitor for age-related comorbidities and potential for increased susceptibility to corticosteroid side effects (e.g., osteoporosis, diabetes, glaucoma).

Clinical Information

💎

Clinical Pearls

  • Ortikos is a locally acting corticosteroid designed to minimize systemic side effects, making it a preferred option for mild to moderate ulcerative colitis compared to systemic corticosteroids.
  • It is crucial to take Ortikos in the morning to align with the body's natural diurnal cortisol rhythm.
  • Patients should be educated about the importance of avoiding grapefruit and grapefruit juice due to significant drug interaction.
  • While systemic side effects are reduced, patients should still be monitored for signs of adrenal suppression, especially if transitioning from other corticosteroids or during periods of stress.
  • Ortikos is for induction of remission, not for maintenance therapy. Patients should be transitioned to appropriate maintenance therapy once remission is achieved.
🔄

Alternative Therapies

  • Other oral corticosteroids (e.g., prednisone, methylprednisolone) for more severe disease or if budesonide is ineffective (with higher systemic side effects).
  • 5-aminosalicylates (5-ASAs) (e.g., mesalamine, sulfasalazine) for mild to moderate ulcerative colitis, often used for maintenance.
  • Immunomodulators (e.g., azathioprine, 6-mercaptopurine) for moderate to severe disease or steroid-dependent patients.
  • Biologic therapies (e.g., infliximab, adalimumab, vedolizumab, ustekinumab) for moderate to severe ulcerative colitis.
  • Janus kinase (JAK) inhibitors (e.g., tofacitinib) for moderate to severe ulcerative colitis.
💰

Cost & Coverage

Average Cost: $1,500 - $2,500 per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Specialty drug)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.